Day

august 7, 2018
Palma, Spain and San Diego, USA, August 6th, 2018 – Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announced the completion of enrollment of its Phase 2b CaLIPSO clinical trial investigating Sanifit’s lead candidate SNF472, for the treatment of cardiovascular calcification (CVC) in end-stage-renal-disease (ESRD) patients on haemodialysis (HD). Most...
I disse dage forbereder fem dygtige medicinstuderende sig på at deltage i Lundbeckfondens forskningsprogram DARE – Danish American Research Exchange. De fem studerende er rejst til San Francisco, hvor de skal forske på Stanford University og University of California, San Francisco. Mette, Cecilie, Mark, Søren og Emma er rejst over Atlanten for at forske i...

Nyheder

Lundbeckfonden vil dække universiteters projektrelaterede indirekte omkostninger
10. december 2018
Danske forskere: Patientforsøg med stamceller mod diabetes nærmer sig
10. december 2018
Professor søges!
5. december 2018

Lundbeckfonden

Lundbeckfonden Ventures

Lundbeckfonden Emerge